Tag Waisman Center
It’s not a cure for Down syndrome that Dave Witte and Cristina Delgadillo want for their 5-year-old daughter. But they would be happy if stem cell research at the Waisman Center reduces the complications faced by Olivia, who has had two heart surgeries and a stroke.
UW–Madison researchers have shown that mice making too much of a human protein called AT-1 show signs of early aging and premature death, which are also symptoms of the human disorder progeria.
A UW–Madison lab that makes proteins, antibodies and viruses has begun manufacturing a virus critical to experimental treatments for many genetic conditions.
Qiang Chang, a longstanding member of the University of Wisconsin–Madison Waisman Center’s leadership team, has been named the new director of the center following a nationwide search.
UW–Madison's Waisman Center is one of the nation’s premier hubs for research and clinical outreach on human development, developmental disability and neurodegenerative disease.
Waisman Center research into the molecular mysteries of Rett Syndrome may ultimately help an 8-year-old girl who suffers from the rare neurological disorder.
Promising results in the lab and in animal models could set the stage for developing a treatment for Alexander disease, a rare and usually fatal neurological disease with no known cure.
Balance challenges are more common among people with ASD, and difficulties with balance are thought to relate to more severe ASD symptoms and impaired activities in daily living.
Children living in neighborhoods where incomes are low and fewer adults have bachelor’s degrees are less likely to be diagnosed with autism spectrum disorder compared to kids from more affluent neighborhoods.
Early recipients of UW2020 funding, from the School of Music to the School of Medicine and Public Health and beyond, have assembled interdisciplinary teams to address their research questions and have attracted outside funding with initial support from the program.
Carl Ross has more than 26 years of experience advancing a wide range of cell and gene therapies, vaccines and therapeutic proteins into human clinical trials.
IRBs are charged with overseeing research involving human subjects, such as this study in the Infant Learning Lab at UW–Madison’s Waisman Center.
Researchers accurately identified individuals with a genetic condition known as fragile X premutation, linked to neurodegenerative disorders, infertility or having a child with fragile X syndrome.